ArticleChemistryOpen2021

Repurposing FDA-Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease.

Chenshu Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.